A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma

PHASE2UnknownINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

August 13, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Ovarian CancerRecurrent Cancer
Interventions
DRUG

CYH33

a Selective PI3Kα Inhibitor

Trial Locations (36)

Unknown

RECRUITING

Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing

RECRUITING

Chinese PLA General Hospital, Beijing

RECRUITING

The First Affiliated Hospital of Chongqing Medical University, Chongqing

RECRUITING

The Southwest Hospital of AMU, Chongqing

RECRUITING

Sun Yat-sen University Cancer Center, Guangdong

RECRUITING

The First Affiliated Hospital, Sun Yat-sen University, Guangdong

RECRUITING

The First Affiliated Hospital of Hainan Medical College, Haikou

RECRUITING

The Third People's Hospital of Hainan Province, Hainan

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

RECRUITING

Harbin Medical University Cancer Hospital, Harbin

RECRUITING

Hubei Cancer Hospital, Hubei

RECRUITING

Hunan Cancer Hospital, Hunan

RECRUITING

Qilu Hospital of Shandong University, Jinan

RECRUITING

Jiangsu Province Hospital, Nanjing

RECRUITING

The People's Hospital Of Guangxi Zhuang Autonomous Region, Nanning

RECRUITING

Qingdao Central Hospital, Qingdao

RECRUITING

Obstetrics & Gynecology Hospital of Fudan University, Shanghai

RECRUITING

Shanghai First Maternity and Infant Hospital, Shanghai

RECRUITING

Xiaohua wu, Shanghai

RECRUITING

West China Second University Hospital, Sichuan University, Sichuan

RECRUITING

Tianjin Medical University General Hospital, Tianjin

RECRUITING

Zhongnan Hospital of Wuhan University, Wuhan

RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

RECRUITING

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang

RECRUITING

Kurume University Hospital, Kurume

NOT_YET_RECRUITING

Osaka University Hospital, Suita

RECRUITING

National Cancer Center Hospital, Chuo Ku

NOT_YET_RECRUITING

Jikei University Hospital, Minato-Ku

RECRUITING

Keio University Hospital, Shinjuku-Ku

NOT_YET_RECRUITING

Shikoku Cancer Center, Matsuyama

RECRUITING

Nagoya University Hospital, Nagoya

NOT_YET_RECRUITING

Niigata University Medical & Dental Hospital, Niigata

RECRUITING

Okayama University Hospital, Okayama

RECRUITING

Hokkaido University Hospital, Sapporo

RECRUITING

Tohoku University Hospital, Sendai

Sponsors
All Listed Sponsors
lead

Haihe Biopharma Co., Ltd.

INDUSTRY